| Full Name | Mindsolutions |
|---|---|
| Speciality | Counselor |
| Location | 2204 N Emerson St, Denver, Colorado |
| Authorized Official Name and Position | Nathalye Moreno (OWNER) |
| Authorized Official Contact | 9704244061 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Mindsolutions 2204 N Emerson St Denver CO 80205-5127 Ph: (970) 424-4061 | Mindsolutions 2204 N Emerson St Denver CO 80205-5127 Ph: (970) 424-4061 |
| NPI Number | 1003428145 |
|---|---|
| Provider Enumeration Date | 08/19/2020 |
| Last Update Date | 01/03/2022 |
| Certification Date | 01/03/2022 |
| Medicare PECOS PAC ID | 1153712815 |
|---|---|
| Medicare Enrollment ID | O20220107000072 |
News Archive
A personalized prognosis for patients diagnosed with triple-negative breast cancer was the goal of a new study by Katherine Varley, PhD, researcher at Huntsman Cancer Institute and assistant professor of oncological sciences at the University of Utah.
The U.S. Chamber of Commerce today commended the approval of comprehensive medical liability reform legislation by the House Judiciary Committee. The legislation – H.R. 5, the Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act – was approved by the committee yesterday by a vote of 18 to 15 and now goes to the full House of Representatives for consideration.
A team of scientists, led by principal investigator David D. Schlaepfer, PhD, professor in the Department of Reproductive Medicine at the University of California, San Diego School of Medicine report that small molecule inhibitors to a protein called focal adhesion kinase (FAK) selectively prevent the growth of ovarian cancer cells as tumor spheroids.
In a comparison of strategies to identify individuals with Lynch syndrome, the most common form of hereditary colorectal cancer (CRC), caused by mutations in certain genes (DNA mismatch repair [MMR] genes), universal tumor MMR testing among certain CRC patients had a greater sensitivity for the identification of Lynch syndrome compared with multiple alternative strategies, although the diagnostic improvement was modest, according to a study in the October 17 issue of JAMA.
A chemical that could potentially be used in eye drops to reverse cataracts, the leading cause of blindness, has been identified by a team of scientists from UC San Francisco (UCSF), the University of Michigan (U-M), and Washington University in St. Louis (WUSTL).
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003428145 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Provider Name | Sarah L Hays |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1053839118 PECOS PAC ID: 6204245400 Enrollment ID: I20210428003223 |
News Archive
A personalized prognosis for patients diagnosed with triple-negative breast cancer was the goal of a new study by Katherine Varley, PhD, researcher at Huntsman Cancer Institute and assistant professor of oncological sciences at the University of Utah.
The U.S. Chamber of Commerce today commended the approval of comprehensive medical liability reform legislation by the House Judiciary Committee. The legislation – H.R. 5, the Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act – was approved by the committee yesterday by a vote of 18 to 15 and now goes to the full House of Representatives for consideration.
A team of scientists, led by principal investigator David D. Schlaepfer, PhD, professor in the Department of Reproductive Medicine at the University of California, San Diego School of Medicine report that small molecule inhibitors to a protein called focal adhesion kinase (FAK) selectively prevent the growth of ovarian cancer cells as tumor spheroids.
In a comparison of strategies to identify individuals with Lynch syndrome, the most common form of hereditary colorectal cancer (CRC), caused by mutations in certain genes (DNA mismatch repair [MMR] genes), universal tumor MMR testing among certain CRC patients had a greater sensitivity for the identification of Lynch syndrome compared with multiple alternative strategies, although the diagnostic improvement was modest, according to a study in the October 17 issue of JAMA.
A chemical that could potentially be used in eye drops to reverse cataracts, the leading cause of blindness, has been identified by a team of scientists from UC San Francisco (UCSF), the University of Michigan (U-M), and Washington University in St. Louis (WUSTL).
› Verified 2 days ago
| Provider Name | Nathalye Carolina Balistrire |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1023449501 PECOS PAC ID: 6608267364 Enrollment ID: I20240112000863 |
News Archive
A personalized prognosis for patients diagnosed with triple-negative breast cancer was the goal of a new study by Katherine Varley, PhD, researcher at Huntsman Cancer Institute and assistant professor of oncological sciences at the University of Utah.
The U.S. Chamber of Commerce today commended the approval of comprehensive medical liability reform legislation by the House Judiciary Committee. The legislation – H.R. 5, the Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act – was approved by the committee yesterday by a vote of 18 to 15 and now goes to the full House of Representatives for consideration.
A team of scientists, led by principal investigator David D. Schlaepfer, PhD, professor in the Department of Reproductive Medicine at the University of California, San Diego School of Medicine report that small molecule inhibitors to a protein called focal adhesion kinase (FAK) selectively prevent the growth of ovarian cancer cells as tumor spheroids.
In a comparison of strategies to identify individuals with Lynch syndrome, the most common form of hereditary colorectal cancer (CRC), caused by mutations in certain genes (DNA mismatch repair [MMR] genes), universal tumor MMR testing among certain CRC patients had a greater sensitivity for the identification of Lynch syndrome compared with multiple alternative strategies, although the diagnostic improvement was modest, according to a study in the October 17 issue of JAMA.
A chemical that could potentially be used in eye drops to reverse cataracts, the leading cause of blindness, has been identified by a team of scientists from UC San Francisco (UCSF), the University of Michigan (U-M), and Washington University in St. Louis (WUSTL).
› Verified 2 days ago
News Archive
A personalized prognosis for patients diagnosed with triple-negative breast cancer was the goal of a new study by Katherine Varley, PhD, researcher at Huntsman Cancer Institute and assistant professor of oncological sciences at the University of Utah.
The U.S. Chamber of Commerce today commended the approval of comprehensive medical liability reform legislation by the House Judiciary Committee. The legislation – H.R. 5, the Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act – was approved by the committee yesterday by a vote of 18 to 15 and now goes to the full House of Representatives for consideration.
A team of scientists, led by principal investigator David D. Schlaepfer, PhD, professor in the Department of Reproductive Medicine at the University of California, San Diego School of Medicine report that small molecule inhibitors to a protein called focal adhesion kinase (FAK) selectively prevent the growth of ovarian cancer cells as tumor spheroids.
In a comparison of strategies to identify individuals with Lynch syndrome, the most common form of hereditary colorectal cancer (CRC), caused by mutations in certain genes (DNA mismatch repair [MMR] genes), universal tumor MMR testing among certain CRC patients had a greater sensitivity for the identification of Lynch syndrome compared with multiple alternative strategies, although the diagnostic improvement was modest, according to a study in the October 17 issue of JAMA.
A chemical that could potentially be used in eye drops to reverse cataracts, the leading cause of blindness, has been identified by a team of scientists from UC San Francisco (UCSF), the University of Michigan (U-M), and Washington University in St. Louis (WUSTL).
› Verified 2 days ago
Unlimited Potential Therapy Services, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4610 S Ulster St, Ste 150, Denver, CO 80237 Phone: 303-290-7407 | |
Pepe Santana, Phd Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 90 Madison St, Suite 402, Denver, CO 80206 Phone: 720-272-0565 | |
Alis Behavioral Health Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1325 S Colorado Blvd Ste B705, Denver, CO 80222 Phone: 888-528-3860 | |
Succeed Aba Co Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 7535 E Hampden Ave Ste 400, Denver, CO 80231 Phone: 463-777-8323 | |
Magnolia Medical Group Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1490 N Lafayette St Ste 104, Denver, CO 80218 Phone: 303-209-5115 | |
Telemedicine Company New York Pc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 501 S Cherry St Ste 1100, Denver, CO 80246 Phone: 720-363-1418 |